510(k) Report

FDA applicant

Eurospital S.P.A.

Trieste, IT5 decisions2000–20190 recalls

FDA records 5 decisions for Eurospital S.P.A. (Trieste, IT) from 2000 to 2019: 5 510(k) clearances. Most are in product codes NXO (Calprotectin, Fecal) and LHI (Set, I.V. Fluid Transfer). Its devices cite 4 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Eurospital”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, immunology panel, where it files most

How often FDA has decided Eurospital S.P.A.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2019

2014: 12016: 12019: 2
2007high 2 (2019) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Eurospital S.P.A. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Eurospital S.P.A.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report